Abstract
The global incidence of invasive Klebsiella pneumoniae liver abscess syndrome (IKPLAS) increases, yet its underlying molecular mechanisms remain elusive, hindering the development of effective therapeutic strategies. In this study, we analyze bacterial molecular profiles and clinical data from patients with KPLA and IKPLAS, and find no significant difference in the molecular characteristics of K. pneumoniae between the two groups, however, we identify elevated blood lactate levels as an independent predictor of IKPLAS. Further investigation reveals that lactate enhances K. pneumoniae virulence by promoting capsular polysaccharide (CPS) biosynthesis. Mechanistically, lactate reduces cyclic adenosine monophosphate (cAMP) levels by downregulating the expression of mannose-specific phosphotransferase system (man-PTS) enzyme IIA-D genes (gfrA, gfrB, gfrC and gfrD). This reduction in cAMP levels enhances CPS biosynthesis by decreasing its binding to the cAMP receptor protein (CRP). Our results highlight lactate's role in enhancing the virulence of K. pneumoniae via the PTS-CRP axis, offering insights into the pathogenesis of IKPLAS.
Introduction
Klebsiella pneumoniae liver abscess (KPLA) is a rising global health threat, particularly in Asia. While most cases remain localized, approximately 20% progress to Invasive K. pneumoniae Liver Abscess Syndrome (IKPLAS). In these cases, the bacteria migrate from the liver to distant sites such as the eyes, brain, or lungs, often resulting in permanent disability or death.
Historically, research has focused on bacterial genetic factors, such as the K1 serotype or specific virulence genes, to explain this invasiveness. However, comparative analysis reveals that genetic profiles alone are insufficient to distinguish between localized and invasive strains.
This study shifts the focus to the host environment, investigating whether the metabolic state of the patient—specifically elevated lactate levels—serves as a trigger for bacterial aggression.
Methods and Materials
The researchers employed a multi-disciplinary approach to investigate the drivers of IKPLAS:
- Clinical Cohort Study: A retrospective analysis of 68 patients was conducted to identify independent risk factors for invasiveness.
- Comparative Genomics: A phylogenetic tree was constructed using 117 K. pneumoniae isolates (68 local from Ren Ji Hospital, Shanghai, and 49 global sequences from NCBI) to assess genetic divergence.
- Transcriptomics (RNA-seq): Strain Kp9925 was exposed to 40 mM sodium lactate to simulate the abscess environment and identify differentially expressed genes (NCBI BioProject PRJNA1180297).
- Molecular Biology: Homologous recombination was used to create knockout mutants (Δman-PTS, Δcrp, Δcps) and complementation strains to map the signaling pathway.
- In Vivo Models: A mouse liver abscess model was utilized to evaluate survival rates, bacterial loads, and tissue damage.
Results
Lactate as a Virulence Trigger
Clinical data identified high blood lactate levels as an independent predictor of IKPLAS (Odds Ratio = 4.547). Experimental results confirmed that lactate directly enhances the virulence of K. pneumoniae by promoting the biosynthesis of capsular polysaccharide (CPS).
Exposure to 40 mM lactate significantly increased CPS production across multiple clinical isolates, leading to enhanced resistance to macrophage phagocytosis. In mouse models, lactate-supplemented bacteria caused higher mortality and more severe systemic inflammation.
The PTS-CRP Signaling Axis
The study mapped the molecular mechanism behind this metabolic response:
- Lactate sensing: Lactate in the environment downregulates the mannose-specific phosphotransferase system (man-PTS) genes (gfrA-D).
- cAMP reduction: The decrease in PTS activity leads to a significant drop in intracellular cyclic adenosine monophosphate (cAMP) levels.
- CRP release: Under normal conditions, the cAMP Receptor Protein (CRP) acts as a negative regulator (a "brake") on capsule production. The drop in cAMP prevents CRP from binding to its target sites.
- Hyper-encapsulation: The release of this regulatory brake allows for increased CPS biosynthesis, effectively "hyper-armoring" the bacteria against the host immune system.
Discussion
This research highlights that K. pneumoniae does not merely utilize host metabolites for nutrition but uses them as sensory cues to adapt its virulence strategy. The identification of the PTS-CRP axis as a metabolic switch for invasiveness provides a new target for therapeutic intervention.
While the study relied on blood lactate as a proxy for the abscess environment, the findings strongly suggest that managing systemic lactate or developing small molecules to stabilize cAMP levels could serve as an "anti-virulence" strategy. Future work should explore the interaction of other PTS systems and metabolites with this signaling axis to fully map the metabolic landscape of K. pneumoniae pathogenesis.
Summary updated